title: Cushing's syndrome with low levels of serum cortisol: the role of inhaled steroids.
authors.affiliation: Department of Endocrinology, Barts and the London School of Medicine.
authors.forename: Ana Catarina
authors.initials: AC
authors.lastname: Matos
authors.forename: Umasuthan
authors.initials: U
authors.lastname: Srirangalingam
authors.forename: Tracy
authors.initials: T
authors.lastname: Barry
authors.forename: Ashley B
authors.initials: AB
authors.lastname: Grossman
mesh_terms: D000280:Administration, Inhalation; D000420:Albuterol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000730:Androstadienes / Q000008:administration & dosage / Q000009:adverse effects*; D001249:Asthma / Q000150:complications / Q000188:drug therapy*; D003480:Cushing Syndrome / Q000139:chemically induced* / Q000175:diagnosis* / Q000628:therapy; D004338:Drug Combinations; D000068297:Fluticasone-Salmeterol Drug Combination; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D055815:Young Adult
chemical_list: D000730:Androstadienes; D004338:Drug Combinations; D000068297:Fluticasone-Salmeterol Drug Combination; D005938:Glucocorticoids; D000420:Albuterol